In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;
Thus , <*> we have created a hybrid surface with the potential
In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ; using a PEG linker on both material and cellular surfaces .
Thus , by inhibiting thromboinflammation using a multicomponent approach , we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation .